David B. Musket - 03 Jan 2023 Form 4 Insider Report for CAPRICOR THERAPEUTICS, INC. (CAPR)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CAPR	Stock Option (Right to Buy)	Award	$0	+37,770	$0.000000	37,770	03 Jan 2023	Common Stock	37,770	$3.85	Direct	F1
transaction	CAPR	Stock Option (Right to Buy)	Award	$0	+16,620	$0.000000	16,620	03 Jan 2023	Common Stock	16,620	$3.85	Direct	F2
transaction	CAPR	Stock Option (Right to Buy)	Award	$0	+19,000	$0.000000	19,000	03 Jan 2023	Common Stock	19,000	$3.85	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The shares vest 1/12th of the first day of each month, commencing February 1, 2023, with the last month vesting on December 31, 2023, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting.
F2	The shares of the award are fully vested and exercisable as of January 3, 2023, the date of the grant. The award pertains to annual board committee service.
F3	The shares of the award are fully vested and exercisable as of January 3, 2023, the date of the grant. The award pertains to annual board service.